Organ Preservation Market - Increasing Initiatives to Encourage Organ Donation

Overview of This Study:

This study involved four major activities in estimating the size of the organ preservation  market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market.

The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through primary research. The bottom-up approach was employed to estimate the overall market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=261269915

Market Size Estimation:

Both top-down and bottom-up approaches were used to estimate and validate the total size of the organ preservation  solution  market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

# The key players in the industry and markets have been identified through extensive secondary research

# The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes

# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Key Questions Addressed by the Report:

# Which solution segment will dominate the organ preservation market in the future?
# Which technique segment will dominate the organ preservation market in the future?
# Emerging countries offer immense opportunities for the growth and adoption of organ preservation market; will this scenario continue in the coming five years?
# What are the upcoming products in the organ preservation market?

Expected Growth in Global Market:

The global organ preservation market is projected to reach USD 284 million by 2024 from USD 207 million in 2019, at a CAGR of 6.5%. The growth of the organ preservation market is mainly driven by the increasing incidence of multi-organ failure, the growing geriatric population, the rising number of organ transplants and organ donors, and increasing initiatives to encourage organ donations. However, the high cost of organ transplantations and religious concerns in specific geographies are expected to limit market growth to a certain extent.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=261269915

“The Asia Pacific to witness the highest growth during the forecast period.”

Asia Pacific is expected to grow at the highest CAGR during the forecast period of 2019–2024. The major factors driving the growth of the Asia Pacific market include favorable government initiatives, increased awareness in people and increased organ donations.

XVIVO Perfusion AB (Sweden), Paragonix Technologies (US), Dr. Franz Kohler Chemie GMBH (Germany) are the leading players in the organ preservation market.

Sample Preparation Market - Technological Advancements in Analytical Instruments Demand Better Samples

Overview of This Study:

The Sample Preparation Technique Market comprises products used to prepare biological as well as chemical samples for the analysis of raw materials or final products primarily to determine the presence of unwanted materials. Sample preparation instruments, workstations, and consumables serve the purpose of the production of a homogeneous sub-sample, representative of the material submitted to a laboratory.

Expected Revenue Growth:

The Sample Preparation Market is expected to grow at a CAGR of 5.5% during the forecast period to reach USD 7,203.2 Million by 2021 from an estimated USD 5,512.2 Million in 2016.

Major Growth Fueling Factors:

The market growth can be attributed to increasing research activities in genomics, shift from manual sample preparation to workstations, global alliances among leading research institutes to boost drug discovery, rising adoption of modern extraction techniques, technological advancements in analytical instruments, increasing life sciences R&D spending, and increasing need for food analysis due to safety concerns.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=66938505

Target Audience:

# Sample preparation instruments, consumables, accessories, and related products manufacturing companies
# Suppliers and distributors of sample preparation instruments, consumables, and accessories
# Research institutes and academic centers
# Pharmaceutical and biopharmaceutical companies
# Biotechnology companies
# Molecular diagnostic companies
# Food and beverage analysis companies
# Business research and consulting service providers
# Environmental testing organizations
# Government departments and agencies
# Venture capitalists

Research Methodology Opted for This Study:

Top-down and bottom-up approaches were used to validate the size of the global sample preparation market and estimate the size of various other dependent submarkets. Various secondary sources such as directories, industry journals, databases such as Hoover’s, Bloomberg Business, Factiva, and Avention, and annual reports of the companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market.

End Users:

On the basis of end user, the sample preparation market is segmented into pharmaceutical and biotechnology industry, research & academic institutes, food and beverage industry, and other end users (clinical research laboratories, forensic laboratories, and environmental testing industry). The pharmaceutical and biotechnology industry segment is expected to account for the largest share of the market in 2016 and is projected to grow at the highest CAGR in the forecast period.

Geographical Growth:

Geographically, the global Sample Preparation Technique Market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (Latin America, Middle East, and Africa). North America is expected to account for the largest share of the sample preparation market in 2016, followed by Europe, Asia-Pacific, and the Rest of the World. The Asia-Pacific market is projected to grow at the highest CAGR, and serves as a revenue pocket for companies offering sample preparation products.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=66938505

Global Key Players:

Prominent players in the global sample preparation market include Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Illumina, Inc. (U.S.), QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Hamilton Company (U.S.), Norgen Biotek Corporation (Canada), Roche Applied Science (Switzerland), Tecan Group (Switzerland), Sartorius (Germany), Merck (Germany), and Promega Corporation (U.S.).

ATP Assay Market - Expected Revenue Growth by 2024

Overview of This Study:

The study involved four major activities in estimating the current size of the ATP assays market. Exhaustive secondary research was conducted to collect information on the market as well as its peer and parent markets. The next step is to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both the top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the sizes of segments and subsegments.

Secondary Research:

In the secondary research process, various secondary sources such as D&B Hoovers, Bloomberg Business, and Factiva have been referred to identify and collect information for this study. These secondary sources included annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold standard & silver standard websites, regulatory bodies, and databases.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=223438780

Primary Research:

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing & sales directors, technology & innovation directors, and related key executives from various key companies operating in the ATP assays market. The primary sources from the demand side included experts such as technical experts. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and burning issues, and key market dynamics such as market drivers, challenges, and opportunities.

Expected Revenue Growth:

The global ATP assays market size is projected to reach USD 315 million by 2024 from USD 191 million in 2019, at a CAGR of 10.5%. Growth in this market is majorly driven by the increasing demand for ATP assays in pharmaceutical & biotechnology companies, rising investments in pharmaceutical & biotechnology R&D, the increasing prevalence of cancer and other chronic and infectious diseases, and the shift from culture-based tests to rapid tests.

By end user, pharmaceutical & biotechnology companies accounted for the largest market share in 2018

Based on end user, the ATP assays market is segmented into pharmaceutical & biotechnology companies, the food & beverage industry, hospitals & diagnostic laboratories, and academic & research institutions. In 2018, the pharmaceutical & biotechnology companies segment accounted for the largest share of the market. ATP assays are emerging as preferred tools for screening potential drug compounds; therefore, many pharmaceutical and biotechnology companies are gradually replacing other in vitro and biochemical assays with cell-based assays, such as ATP assays, in drug discovery. Owing to the increasing adoption of cell-based assays, the use of ATP assay kits is also likely to increase in the coming years.

Recent Developments:

# In March 2019, Promega launched the Water-Glo reagent, which uses bioluminescent technology to measure ATP and is used for monitoring microbial contamination in freshwater, process water, seawater, or wastewater samples.

# In August 2018, Hygiena acquired Biomedal’s Food Safety division. Under this acquisition, the new division will be named Hygiena Diagnóstica España and will provide allergen tests and assays in the market.

# In February 2018, Merck invested around USD 44 million (~EUR 40 million) for expanding its manufacturing and distribution centers in South Korea, India, and China.

# In August 2017, Hach (a subsidiary of Danaher Corporation) expanded its Loveland, US campus by inaugurating a new facility for R&D.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=223438780

Asia Pacific is expected to witness the highest growth in the ATP assays market from 2019 to 2024

The global ATP assays market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. During the forecast period, the Asia Pacific market is estimated to grow at the highest CAGR, as several countries are witnessing a growing number of proteomics, genomics, and stem cell research activities, increasing research funding, rising investments by pharmaceutical & biotechnology companies, and the growing trend of research infrastructure modernization.

Key Players:

The prominent players in the global ATP assays market are Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (US), PerkinElmer, Inc. (US), Lonza Group (Switzerland), Promega Corporation (US), Agilent Technologies, Inc. (US), Abcam plc. (UK), Danaher Corporation (US), Hygiena, LLC. (US), BioThema AB (Sweden), Abnova Corporation (Taiwan), AAT Bioquest (US), PromoCell GmbH (Germany), BioVision, Inc. (US), Geno Technology, Inc. (US), Biotium (US), Canvax Biotech S.L. (Spain), Creative Bioarray (US), Elabscience (US) and MBL International Corporation (US).

Tracheostomy Products Market - Future Growth Trends & Revenue Growth Expectations

Recent Developments in the Global Tracheostomy Surgical Procedures Market:

# In February 2019, Medtronic Plc entered into a partnership with Medical University of South Carolina (US) for the development of better and affordable healthcare solutions (including tracheostomy procedure for breathing assistance) for patients

# In October 2017, Medtronic Plc established the Chengdu Innovation Center at Singapore for cross-disciplinary clinical training and R&D.

Key Questions Addressed by the Report:

# Emerging countries are offering immense opportunities for the growth and adoption of market. Will this scenario continue in the coming years?

# Where will all the advancements in products offered by various companies take the industry in the mid-to-long term?

# What are the various research institutes where tracheostomy products find a high adoption rate?

# What are the new trends and advancements in the market?

# How is the shift in dynamics shaping the future of the market?

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=79626751

Market Size Estimation:

Top-down and bottom-up approaches were used to estimate and validate the total size of the tracheostomy products market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

# The key players in the industry and markets have been identified through extensive secondary research

# The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research

# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation:

After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the tracheostomy industry.

Expected Revenue Growth:

The tracheostomy products market size is projected to reach USD 220 million by 2024 from USD 179 million in 2019, at a CAGR of 4.2% during the forecast period. Growth in the tracheostomy products industry is driven primarily by the growing public awareness related to tracheostomy procedures among medical professionals, increasing prevalence of respiratory diseases & disorders, and availability of medical reimbursement and insurance coverage.

Hospitals & surgical centers segment accounted for the largest share of the tracheostomy products market, by the end-user, in 2018

Hospitals & surgical centers were the largest application segment of the tracheostomy products industry, and this trend is expected to continue during the forecast period. A large number of private enterprises are taking steps to cater to the needs of modern, which has resulted in the large share of this segment. Other significant factors include well-equipped state-run healthcare facilities in these regions and growing healthcare consolidation to improve access to healthcare services.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=79626751

North America dominates the tracheostomy products market

The market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the market in 2018. Factors such as the presence of a highly developed healthcare system, an increasing number of emergency department visits, high adoption of innovative tracheostomy devices among medical professionals, and wide availability of advanced tracheostomy devices are driving the market for tracheostomy products in North America.

The major players operating in the tracheostomy products market are Medtronic plc (Ireland), Smiths Group plc (UK), TRACOE Medical GmbH (Germany), Teleflex Incorporated (US), and Fisher & Paykel Healthcare Ltd. (New Zealand). Other prominent players operating in this market include ConvaTec Group (US), Cook Group (US), Troge Medical GmbH (Germany), Well Lead Medical Co., Ltd. (US), Fuji Systems Corporation (Japan), Andreas Fahl Medizintechnik-Vertrieb GmbH (Germany), Xinxiang Huaxi Sanitary Materials Co., Ltd. (China), Medis Medical (Tianjin) Co. Ltd. (China), Boston Medical (US), and Pulmodyne (US)..

Organ Preservation Market - Future Revenue Growth Dynamics

Overview of This Study:

This study involved four major activities in estimating the size of the Organ Preservation Devices Market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through primary research. The bottom-up approach was employed to estimate the overall market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.

Market Size Estimation:

Both top-down and bottom-up approaches were used to estimate and validate the total size of the organ preservation  solution  market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

# The key players in the industry and markets have been identified through extensive secondary research

# The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes

# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=261269915

Key Questions Addressed by the Report:

# Which solution segment will dominate the organ preservation market in the future?
# Which technique segment will dominate the organ preservation market in the future?
# Emerging countries offer immense opportunities for the growth and adoption of organ preservation market; will this scenario continue in the coming five years?
# What are the upcoming products in the Organ Preservation Devices Market?

Data Triangulation:

After arriving at the overall market size-using the market size estimation processes as explained above-the market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides, in the provider, payer, and other industries.

Report Objectives:

# To define, describe, and forecast the organ preservation  market on the basis of provider, delivery mode, application, end user, and region.

# To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges).

# To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market.

# To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.

# To forecast the size of the market segments with respect to four main regions—North America, Europe, Asia Pacific, and the Rest of the World (RoW).

# To profile the key players and comprehensively analyze their market shares and core competencies

# To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, collaborations, and approvals in the global Organ Preservation Devices Market

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=261269915

Expected Revenue Growth:

The global organ preservation market is projected to reach USD 284 million by 2024 from USD 207 million in 2019, at a CAGR of 6.5%. The growth of the organ preservation market is mainly driven by the increasing incidence of multi-organ failure, the growing geriatric population, the rising number of organ transplants and organ donors, and increasing initiatives to encourage organ donations. However, the high cost of organ transplantations and religious concerns in specific geographies are expected to limit market growth to a certain extent.

Major Growth Strategy Adopted by Players in the Sample Preparation Market

The overall Sample Preparation Research Technique Market comprises of different players securing leadership position in different product lines. For instance, QIAGEN N.V. (The Netherlands) leads the sample preparation automated workstation market whereas Thermo Fisher Scientific, Inc. (U.S.) and Tecan Group Ltd. (Switzerland) dominate the automated liquid handling systems market.

Other players having significant presence in Sample Preparation Market include Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Illumina, Inc.(U.S.), PerkinElmer, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Norgen Biotek Corporation (Canada), Hamilton Company (U.S.), Merck (U.S.), Promega Corporation (U.S.), and Roche Applied Science (U.S).

QIAGEN N.V. is among the leading players in the Sample Preparation Research Technique Market. A wide product portfolio, high focus on increasing company presence in the emerging economies, and continuous launch of new and innovative products are contributing to the company’s dominance in this market. The company has high focus on innovation through the launch of new products. During 2013 to 2016 the company launched several sample preparation products and solutions. For instance, in February 2016, QIAGEN expanded its portfolio of ‘Sample to Insight’ solutions with the launch of more than 170 new QIAseq Targeted RNA Panels for gene expression profiling.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=66938505

Thermo Fisher Scientific, Inc. is another major player in the sample preparation market. The company has a well-established brand and has operations in over 150 countries. Acquisition is preferred choice of strategy adopted by the company to expand its product portfolio and enter into emerging businesses. For instance, in 2016, the company acquired Affymetrix, Inc. (U.S.) to strengthen its laboratory equipment offerings, which include diagnostic tools for hospitals and mass spectrometers for chemists.

PerkinElmer, Inc. (U.S.) is another dominant player in the global sample preparation market. The company is a leading provider of products, services, and solutions to the diagnostics, research, environmental, industrial, and laboratory services markets. The company strategically focuses on expanding its presence in emerging economies. For instance in 2016, PerkinElmer expanded its footprint in India by opening a new diagnostics facility in India. Similarly, the company established a subsidiary in China called Suzhou PerkinElmer Medial Laboratory Co. ltd (in 2015) and direct operations in Israel (in 2013) to provide products and customer service.

The other players in Sample Preparation Research Technique Market have implemented various strategies to expand their global footprint and increase their market share. Major growth strategies followed by market players include new product launches, agreements, collaborations, and partnerships. New product launches accounted for major share followed by agreements, collaborations, and partnerships which accounted for the second-largest share of the total number of key growth strategies adopted by players in the sample preparation market during 2013 to 2016. Acquisitions, product enhancement, and other developments (market promotions and grants) are some of the other strategies adopted by players to achieve growth in the sample preparation market.

The sample preparation market comprises products used to prepare biological as well as chemical samples for the analysis of raw materials or final products primarily to determine the presence of unwanted materials. Sample preparation instruments, workstations, and consumables serve the purpose of the production of a homogeneous sub-sample, representative of the material submitted to a laboratory.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=66938505

Global Revenue Growth:

The market is expected to grow at a CAGR of 5.5% during the forecast period to reach USD 7,203.2 Million by 2021 from an estimated USD 5,512.2 Million in 2016.

The Sample Preparation Research Technique Market growth can be attributed to increasing research activities in genomics, shift from manual sample preparation to workstations, global alliances among leading research institutes to boost drug discovery, rising adoption of modern extraction techniques, technological advancements in analytical instruments, increasing life sciences R&D spending, and increasing need for food analysis due to safety concerns.

ATP Assay Market - Future Growth Dynamics & Expected Revenue Growth

Recent Developments ATP Assay Market:

# In March 2019, Promega launched the Water-Glo reagent, which uses bioluminescent technology to measure ATP and is used for monitoring microbial contamination in freshwater, process water, seawater, or wastewater samples.

# In August 2018, Hygiena acquired Biomedal’s Food Safety division. Under this acquisition, the new division will be named Hygiena Diagnóstica España and will provide allergen tests and assays in the market.

# In February 2018, Merck invested around USD 44 million (~EUR 40 million) for expanding its manufacturing and distribution centers in South Korea, India, and China.

# In August 2017, Hach (a subsidiary of Danaher Corporation) expanded its Loveland, US campus by inaugurating a new facility for R&D.

North America dominates the ATP assays industry:

The global market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest share of the market. The growth of the market in North America is mainly driven by increasing investments in cancer and stem cell research, increasing demand for technologically advanced instruments in research and diagnostic applications, and the high prevalence of chronic diseases coupled with the increasing demand for early and effective disease diagnosis and treatment. The favorable reimbursement policies, high disposable income, and the presence of superior healthcare and research infrastructure are also supporting market growth.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=223438780

End Users:

By end user, pharmaceutical & biotechnology companies accounted for the largest market share in 2018

Based on end user, the ATP assays market is segmented into pharmaceutical & biotechnology companies, the food & beverage industry, hospitals & diagnostic laboratories, and academic & research institutions. In 2018, the pharmaceutical & biotechnology companies segment accounted for the largest share of the market. ATP assays are emerging as preferred tools for screening potential drug compounds; therefore, many pharmaceutical and biotechnology companies are gradually replacing other in vitro and biochemical assays with cell-based assays, such as ATP assays, in drug discovery. Owing to the increasing adoption of cell-based assays, the use of ATP assay kits is also likely to increase in the coming years.

Global Key Players:

The prominent players in the global ATP assays market are Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (US), PerkinElmer, Inc. (US), Lonza Group (Switzerland), Promega Corporation (US), Agilent Technologies, Inc. (US), Abcam plc. (UK), Danaher Corporation (US), Hygiena, LLC. (US), BioThema AB (Sweden), Abnova Corporation (Taiwan), AAT Bioquest (US), PromoCell GmbH (Germany), BioVision, Inc. (US), Geno Technology, Inc. (US), Biotium (US), Canvax Biotech S.L. (Spain), Creative Bioarray (US), Elabscience (US) and MBL International Corporation (US).

Key Questions Addressed in the Report

# Which are the top 10 players operating in the ATP assays market?
# What are the drivers, restraints, opportunities, and challenges of the market?
# What are the prevailing industry trends, and what is the current scenario in the market?
# What are the growth trends in the market at the segmental and overall levels?
# How is the market performing in different regions across the globe?

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=223438780

Data Triangulation:

After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Expected Revenue Growth:

The global ATP assays market size is projected to reach USD 315 million by 2024 from USD 191 million in 2019, at a CAGR of 10.5%. Growth in this market is majorly driven by the increasing demand for ATP assays in pharmaceutical & biotechnology companies, rising investments in pharmaceutical & biotechnology R&D, the increasing prevalence of cancer and other chronic and infectious diseases, and the shift from culture-based tests to rapid tests.

Tracheostomy Products Market - Technological Advancements to Boost the Global Industry Revenue

Overview of This Study:

The study involved four major activities in estimating the current size of the Tracheostomy Surgery Market. Exhaustive secondary research was carried out to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments.

Market Size Estimation:

Top-down and bottom-up approaches were used to estimate and validate the total size of the tracheostomy products market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

# The key players in the industry and markets have been identified through extensive secondary research

# The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research

# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=79626751

Recent Developments in the Global Tracheostomy Surgery Market:

# In February 2019, Medtronic Plc entered into a partnership with Medical University of South Carolina (US) for the development of better and affordable healthcare solutions (including tracheostomy procedure for breathing assistance) for patients

# In October 2017, Medtronic Plc established the Chengdu Innovation Center at Singapore for cross-disciplinary clinical training and R&D.

The tracheostomy tubes segment is expected to register the highest CAGR during the forecast period

Tracheostomy tubes are utilized in the tracheostomy procedures that are performed in the case of conditions such as anaphylaxis, throat cancer, chronic lung disease, coma, diaphragm dysfunction, laryngectomy, obstructive sleep apnea, and vocal cord paralysis. The high growth of the tracheostomy tubes segment can be attributed to the significant benefits offered such as high accuracy, reduced air pollution & risk of aspiration, avoids multiple laryngoscopies & intubations, improved ventilation & accurate tidal volume, and end-tidal carbon dioxide monitoring.

By technique, the ciaglia blue rhino tracheostomy segment accounted for the largest share of the tracheostomy products market in 2018

Ciaglia blue rhino tracheostomy works in one-step dilation instead of the typically used sequential dilators. The large share of this segment is attributed to the ease of operation (owing to its slippery coating), low risk of damaging the membranous tracheal wall, rapid insertion (owing to the passage of a single dilator), limited hazard of bleeding at the lower level, low risk of cardiac dysrhythmias, and lack of damage of the curved dilator tip & kinking of the guiding catheter.

Key Questions Addressed by the Report:

# Emerging countries are offering immense opportunities for the growth and adoption of market. Will this scenario continue in the coming years?
# Where will all the advancements in products offered by various companies take the industry in the mid-to-long term?
# What are the various research institutes where tracheostomy products find a high adoption rate?
# What are the new trends and advancements in the Tracheostomy Surgery Market?
# How is the shift in dynamics shaping the future of the market?

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=79626751

End Users

Hospitals & surgical centers will continue to dominate the tracheostomy products market during the forecast period

Hospitals & surgical centers formed the largest end-users of tracheostomy devices in 2018. This segment is also expected to grow at the highest rate during the forecast period. The growth of this market segment is attributed to the financial capabilities of hospitals to purchase expensive equipment and the availability of trained professionals to operate tracheostomy devices. The increase in this market is attributed to a large number of private enterprises are taking steps to cater to the needs of modern, well-equipped state-run healthcare facilities, and rapid developments in healthcare infrastructure & improving access to healthcare services.

Geographical Growth Scenario:

North America is the largest regional market for tracheostomy products

North America is one of the major revenue-generating regions in the market. The presence of a highly developed healthcare system, increasing number of emergency department visits, high adoption of innovative tracheostomy devices among medical professionals, wide availability of advanced tracheostomy devices, the large number of tracheostomy devices manufacturing companies that have an established base, and the rising prevalence of chronic respiratory diseases are driving the growth of the tracheostomy products industry in North America.

Global Key Players:

Medtronic plc (Ireland), Smiths Group plc (UK), TRACOE Medical GmbH (Germany), Teleflex Incorporated (US), and Fisher & Paykel Healthcare Ltd. (New Zealand) were the top five players in the global Tracheostomy Surgery Market. Other prominent players operating in this market include ConvaTec Group (US), Cook Group (US), Troge Medical GmbH (Germany), Well Lead Medical Co., Ltd. (US), Fuji Systems Corporation (Japan), Andreas Fahl Medizintechnik-Vertrieb GmbH (Germany), Xinxiang Huaxi Sanitary Materials Co., Ltd. (China), Medis Medical (Tianjin) Co. Ltd. (China), Boston Medical (US), and Pulmodyne (US), among others.

Read More Detailed Article@
https://www.marketsandmarkets.com/Market-Reports/tracheostomy-product-market-79626751.html

Specimen Retrieval Market - Future Trends to Boost Global Market Revenue

Overview of This Study:

The study involved four major activities in estimating the current size of the specimen retrieval systems market. Exhaustive secondary research was conducted to collect information on the market and its subsegments.

The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Data Triangulation:

After arriving at the overall market size using the market size estimation processes the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the specimen retrieval systems industry.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=126359758

Market Size Estimation:

Both top-down and bottom-up approaches were used to estimate and validate the total size of the specimen retrieval systems market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

# The key players in the industry and markets have been identified through extensive secondary research

# The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes

# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Expected Revenue Growth:

The specimen retrieval systems market is expected to grow from USD 230 million in 2019 to USD 290 million by 2024, at a compound annual growth rate (CAGR) of 4.7% during the forecast period. The major factors driving the growth of this market include the increasing prevalence of diseases requiring surgical treatment and removal of specimens from the body, especially laparoscopic procedures.

Key questions addressed in the report:

# What are the growth opportunities in the specimen retrieval systems market across major regions in the future?

# Emerging countries have immense opportunities for the growth and adoption of specimen retrieval systems. Will this scenario continue during the next five years?

# Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?

# What are the various specimen retrieval systems and their respective market shares in the overall market?

# What are the new trends and advancements in the specimen retrieval systems market?

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=126359758

Hospitals were the largest end users of specimen retrieval systems in 2018

By end user, the specimen retrieval systems market is segmented into hospitals and other end users. The hospitals segment accounted for the largest market share in 2018 and is expected to register the highest growth during the forecast period. The large share and high CAGR of this segment can be attributed to the robust infrastructure and presence of skilled professionals in hospitals, which has driven the preference for hospital-based treatment.

North America commanded the largest share of the specimen retrieval systems market in 2018

North America dominates the specimen retrieval systems market. The large share of North America in this market can be attributed to the increasing incidence and prevalence of cancer, hernia, and appendectomy and the availability of reimbursement for laparoscopic surgeries in the region. 

Environmental Testing Equipment Market - Increasing Industrial Activities in Emerging Markets

Data Triangulation:

After arriving at the overall market size using the market size estimation processes as explained above the market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both, the demand and supply sides, in the environmental testing equipment industry.

Market Size Estimation:

Both top-down and bottom-up approaches were used to estimate and validate the total size of the environmental testing equipment market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

# The key players in the industry and markets have been identified through extensive secondary research

# The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes

# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=149706080

Recent Developments:

# In March 2018, Agilent established a new logistics hub in Shanghai to enable rapid delivery of the company’s instrument parts, supplies, and consumables to laboratories in China.

# In August 2016, Shimadzu acquired SINC (SINC do Brasil Instrumentaçâo Cientifica Ltda.) to strengthen its analytical and measuring instruments business in Brazil.

Overview of This Study:

The study involved four major activities to estimate the current market size for environmental testing equipment. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter market breakdown and data triangulation was used to estimate the market size of segments and subsegments

Key questions addressed by the report:

# Which of the product segment will dominate the global market in the next five years?
# Emerging countries have immense opportunities for the growth and adoption of environmental testing equipment, will this scenario continue in the next five years?
# Increasing environmental awareness in the emerging market is impacting the growth for developed markets. How will the pricing difference impact the overall market?
# What are the upcoming technologies in the global market?

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=149706080

Air testing applications are expected to grow at the highest CAGR in the global environmental testing equipment market during the forecast period

On the basis of application, the market is segmented into water testing, air testing, and soil testing. The water testing segment commanded the largest share of the market in 2018. However, the air testing market is projected to register the highest CAGR owing to the increasing fatalities caused by severe air pollution levels. Increasing fatalities caused by severe air pollution levels is a major factor driving growth in the application segment.

North America is expected to dominate the environmental testing equipment market during the forecast period

Geographically, North America is expected to dominate the global environmental testing equipment market in 2018, while the Asia Pacific region is expected to register the highest CAGR during the forecast period. The high growth in this region can be attributed to the rising outdoor air pollution levels, the availability of government funding, and stringent environmental monitoring regulations.

Electrosurgery Market - Emerging Trends are Majorly Boosting the Global Industry Revenue

Key Questions Addressed by the Report:

# What are the growth opportunities related to the adoption of electrosurgery devices and instruments across major regions in the future?

# Emerging countries have immense opportunities for the growth and adoption of electrosurgery devices and instruments. Will this scenario continue in the next five years?

# Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?

# What are the new trends and advancements in the electrosurgery market

# What are the different trends and dynamics that will shape the future of the global market?

Overview of This Study:

The study involved four major activities in estimating the current market size for the electrosurgery market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=142006761

The hospitals, clinics, & ablation centers segment accounted for the largest share of the electrosurgery market in 2018.

On the basis of end users, the electrosurgery market is segmented into hospitals, clinics, & ablation centers; ambulatory surgical centers; and research laboratories & academic institutes. The hospitals, clinics, & ablation centers segment accounted for the largest market share in 2018. The large share of this segment can be attributed to a large number of electrosurgery procedures performed in hospitals, the growing demand for minimally invasive procedures, and the rising adoption of advanced imaging modalities to improve workflow efficiency in hospitals.

The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period

On the basis of region, the electrosurgery market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest share of the electrosurgery market, followed by Europe. However, the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period, primarily due to the growing popularity of cosmetic surgeries, government efforts to increase access to elective surgery, large population base, high patient population, and improving healthcare infrastructure in the region.

The electrosurgical instruments segment accounted for the largest share of the electrosurgery market in 2018.

Based on products, the electrosurgery market is segmented into electrosurgical instruments, electrosurgical generators, electrosurgical accessories, and smoke evacuation systems. The electrosurgical instruments segment accounted for the largest share of the global electrosurgery market in 2018. The large share of this segment can be attributed to the high usage volume of disposable and reusable electrosurgical instruments. In addition, technological advancements in electrosurgical instruments and the increasing number of cosmetic and plastic surgeries are stimulating the growth of this segment.

The general surgery segment accounted for the largest share of the electrosurgery market in 2018.

On the basis of type of surgery, the electrosurgery market is segmented into general surgery, gynecology surgery, urological surgery, orthopedic surgery, cardiovascular surgery, cosmetic surgery, neurosurgery, oncological surgery, and other surgeries. The general surgery segment accounted for the largest share of the electrosurgery market in 2018. The large share of this segment can be attributed to the rising geriatric population and the subsequent increase in the prevalence of various diseases/conditions, the growing volume of surgical procedures performed, and the rising prevalence of obesity.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=142006761

Key Players:

In 2018, Medtronic (Ireland), Ethicon (US), and Olympus (Japan) dominated the electrosurgery market. Other prominent players in this market include CONMED (US), B. Braun Melsungen AG (Germany), Applied Medical (Netherlands), Erbe Elektromedizin GmbH (Germany), Kirwan Surgical Products LLC (US), Bovie Medical Corporation (US), BOWA-electronic GmbH & Co. KG (Germany), KLS Martin Group (Germany), Boston Scientific (US), Smith & Nephew plc (UK), and CooperSurgical Inc. (US).

ePrescribing Market - Increasing Adoption of EHR Solutions

Methodology:

The study involved four major activities in estimating the size of the global ePrescribing market. Exhaustive secondary research was done to collect information on the utilization of different solutions and their regional utilization trends. Industry experts further validated the data obtained through secondary research through primary research.

Furthermore, the market size estimates and forecast provided in this study are derived through a mix of the bottom-up approach (country-level adoption of various EHR solutions and utilization of ePrescribing funcitonality) and top-down approach (assessment of utilization/adoption/penetration trends, by type of product& service, delivery mode, end user, and region). After that, market breakdown and data triangulation methods were used to estimate the market size of segments and subsegments.

Secondary Research:

Various secondary sources such as the World Health Organization (WHO), Healthcare Information and Management Systems Society (HIMSS), National Association of Healthcare Quality, California Association of Public Hospitals and Health Systems (CAPH), Centers for Medicare and Medicaid Services (CMS), RAND Europe, Australian Digital Health Agency, annual reports/SEC filings as well as investor presentations and press releases of key players have been used to identify and collect information useful for the study of this market.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=910

Primary Research:

Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess the dynamics of this market. The primary sources from the supply side include CEOs, vice presidents, marketing and sales directors, business development managers, technology and innovation directors, and key opinion leaders. Primary sources from the demand side include personnel from hospitals, ambulatory care centers, clinics, and pharmacies.

COVID-19 Impact on ePrescribing Market:

The COVID-19 pandemic will not directly impact the e-prescribing market; however, its impact on the healthcare IT and the EMR markets will drive the demand for e-prescribing solutions during and after the global pandemic. Due to the COVID-19 outbreak, the number of teleconsultations has increased. The integration of EHR, telemedicine, and e-prescribing functionalities aid prescribers in creating an interconnected network that ensures the use of HCIT to diagnose and prescribe medicines for patients. In addition, recommendations by the CDC to use telemedicine services and the Drug Enforcement Administration (DEA) regulations for the electronic prescription of controlled substances have increased the number of electronic prescription transactions.

Strategies adopted by EHR and EMR vendors during COVID-19:

# Cerner Corporation (US) integrated its EHR platform with telehealth capabilities, which would help improve patient access to healthcare from home.

# eClinicalWorks (US) integrated its EHR solution with TeleVisits to help with virtual patient care. TeleVisits is a secure platform that uses existing equipment and webcams to diagnose patients remotely.

# Allscripts (US) implemented telehealth solutions through its EHR patient engagement platform, which would enable its clients to access virtual care services. In March 2020, Allscripts had provided telehealth services to over 100 customers.

Drivers: Increased adoption of EHR solutions

Growing government support for the adoption of EHR solutions and the need to curtail the escalating healthcare costs are the major factors driving the demand for such solutions. In addition, the COVID-19 outbreak worldwide has led to a larger patient volume in hospitals and the need to better manage patient data. This is expected to further drive the demand for these solutions.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=910

North America will continue to dominate the ePrescribing market in 2025

In 2019, the large share of this North American region can be attributed to the stringent legislative and accreditation requirements regarding healthcare, high adoption of HCIT technologies, regulatory requirements regarding patient safety, and the presence of a large number of e-prescribing solution providers in the region.

Prominent players in the global e-prescribing market are Epic Systems Corporation (US), Cerner Corporation (US), Allscripts (US), NextGen Healthcare (US), athenahealth, Inc. (US), RelayHealth, LLC (US), Henry Schein, Inc. (US), GE Healthcare (US), Computer Programs and Systems Inc. (US), DrFirst, Inc. (US), Surescripts-RxHub, LLC (US), and Medical Information Technology, Inc. (US).

Sleep Apnea Devices Market - Future Growth Dynamics & Global Leaders

Market Size Estimation:

Both top-down and bottom-up approaches were used to estimate and validate the total size of the sleep apnea devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

# The key players in the industry and markets have been identified through extensive secondary research

# The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes

# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation:

After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both, the demand and supply sides, in the sleep apnea devices industry.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=719

Expected Revenue Growth:

The global sleep apnea devices market is expected to reach USD 7.5 billion by 2024 from USD 4.5 billion in 2019 at a CAGR of 10.7%. The major factors driving the growth of the sleep apnea devices market are primarily a large pool of undiagnosed sleep apnea patients, growing awareness about the ill effects of untreated sleep apnea, growing usage of oral appliances, technological advancements in sleep apnea devices, considerable venture capital funding, and an increasing number of companies venturing into sleep apnea and oral appliances markets.

Report Objectives:

# To define, describe, and measure the global market by type, end user, and region

# To provide detailed information about major factors influencing market growth (such as drivers, restraints, growth opportunities, and challenges)

# To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the global market

# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

# To forecast the size of the market in North America, Europe, Asia Pacific (APAC), and the Rest of the world (RoW)

# To strategically analyze the market structure and profile key players and their core competencies3 in the global market

# To track and analyze competitive developments such as service launches, expansions, acquisitions, partnerships & collaborations; in the market.

Restraint: High cost of CPAP machines:

In most developed countries, the cost of a CPAP device is either reimbursed or provided by medical insurance companies. The main reason for non-adherence is non-acceptance on the part of the patient, mainly due to the mask causing discomfort or claustrophobia. However, conditions are different in most developing countries, where insurance access is minimal and insurance companies usually do not cover the cost of a CPAP device.

In countries like India, CPAP is not covered by private insurance companies. Only some government employees are able to be reimbursed for CPAP therapy, and that too reimbursement ranges from 30% to 100% depending on the reimbursement rules of various government offices. CPAP is generally an out-of-pocket expense for most of the Indian population. This is a major limiting factor for therapy adoption in these countries.

Similar factors affect the CPAP compliance rate among patients in other South Asian countries as well. For instance, in Singapore, the cost of a CPAP machine is substantial, with an auto-titrating CPAP device costing between USD 1,100–USD 1,500 (1,500–2,000 SGD approximately), which would be nearly half the median monthly income of the average Singaporean worker. Thus, high CPAP device costs act as a restraining factor for the global sleep apnea devices market, especially in developing countries.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=719

Home care settings/individuals projected to grow at the highest CAGR in the global sleep apnea devices market during the forecast period

On the basis of end user, the sleep apnea devices market has been segmented into sleep laboratories & hospitals and home care settings/individuals. The sleep laboratories & hospitals segment accounted for the largest share of the market in 2018, while home care settings/individuals end-user segment is projected to grow at the highest CAGR during the forecast period. This high growth is likely driven by factors such as the rising preference for home sleep testing by both patients and private insurance companies, along with the favorable reimbursement scenario for home sleep testing.

North America is expected to dominate the sleep apnea devices market during the forecast period

On the basis of region, North America accounted for the largest share of the global sleep apnea devices market in 2018, whereas, the Asia Pacific region registered the highest CAGR during the forecast period. North American accounted for the largest share owing to factors like an increase in the number of patients diagnosed with sleep apnea in the region, growth in awareness initiatives being taken by various government and non-government organizations, availability of adequate funding for research and development, and substantial growth in the usage of oral appliances in the region.

Key Players:

Major players operating in the sleep apnea devices market include ResMed (US), Koninklijke Philips (Netherlands), Fisher & Paykel Healthcare (New Zealand), SomnoMed (US), Oventus Medical (Australia), Compumedics (Australia), Löwenstein Medical (Germany), Drive DeVilbiss Healthcare (US), BMC Medical (China), Braebon Medical (Canada), and Panthera Dental (Canada).

Read More Detailed Report@
https://www.marketsandmarkets.com/Market-Reports/sleep-apnea-devices-market-719.html

Medical Equipment Maintenance Market - Innovation in Service Offerings and Use of IoT

Global Market Dynamics:

Driver: Rising focus on preventive medical equipment maintenance

The focus on preventive maintenance of medical equipment has grown in recent years, as healthcare institutions seek to enhance patient safety and care quality. This involves a carefully designed program where maintenance tasks are performed in a scheduled manner to avoid larger and costly repairs down the line. It also helps in reducing equipment downtime, which enhances day-to-day operations and improves device reliability.

The preventive maintenance approach is gaining prominence as planned inspections and medical device maintenance help avoid adverse incidents and medical device-related accidents. Regular maintenance services ensure safe, efficient, and long-lasting use of medical devices. The growing focus on implementing preventive maintenance strategies among healthcare organizations is expected to offer growth opportunities for service providers in the coming years.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=69695102

Restraint: High initial cost and significant maintenance expenditure

Maintenance programs for medical devices enable healthcare providers to track and monitor their condition, and thereby ensure efficient utilization and maximum uptime. This is also essential, given the current focus on preventive maintenance and cost pressures, to control total expenditure against a background of austerity measures. Such programs include the deployment of asset management solutions which use advanced technologies.

However, the deployment of these solutions incurs high initial installation costs and significant maintenance expenditure, while the installation of advanced medical equipment incurs a service contract cost (~12% of the cost of medical equipment) to be paid per year. The service cost thus paid during the lifespan of the equipment is usually more than the cost of the equipment. The high cost associated with the purchase and maintenance of advanced medical equipment is restraining end users from adopting them. This stifles the demand for associated maintenance services and thereby restrains market growth.

North America to account for the largest market size during the forecast period.

North America is expected to hold the largest market size in medical equipment repair market during the forecast period, followed by the European region. Factors such as the growing aging population and rising incidence of lifestyle-related diseases, access to quality healthcare, well-established healthcare infrastructure, high adoption of advanced technology, and the presence of prominent players are driving the North American medical devices industry in this region.

This will significantly boost the growth of the market for associated maintenance services in the region. Additionally, the availability of funding to purchase advanced medical technologies—through investments and similar initiatives—for hospitals and healthcare providers is also expected to aid market growth.

Asia is the third-largest market for medical equipment repair market and is slated to register the highest CAGR of during the forecast period. Factors contributing to this growth include increasing patient population, rising awareness on the benefits of early disease diagnosis, increasing public and private funding for the development of healthcare facilities, government initiatives for the modernization of healthcare infrastructure & provision of quality care, and the growing medical tourism in Asian countries.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=69695102

The market for private-sector organizations is expected to grow at the highest CAGR in the medical equipment maintenance market during the forecast period.

On the basis of end user, the medical equipment maintenance market is segmented into public-sector organizations and private-sector organizations. In 2018, private-sector organizations are expected to register the highest CAGR during the forecast period. The increasing number of public-private partnerships is expected to boost the demand for medical equipment maintenance services.

Expected Revenue Growth:

The Medical Equipment Maintenance Market is expected to grow from USD 28.97 billion in 2018 to USD 47.49 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 10.4% during the forecast period.

In Situ Hybridization Market - Emerging Trends & Global Future Forecasts

Expected Revenue Growth:

The global in situ hybridization market size is projected to reach USD 1.3 billion by 2025 from USD 0.9 billion in 2020, at a CAGR of 7.4% during the forecast period. The increasing incidence of cancer and genetic disorder and awareness of ISH based companion diagnostics tests are the major factors driving the growth of this market.

The cancer diagnostic segment accounted for the largest share of the application segment in the ISH market

Based on the application, the in situ hybridization market is segmented broadly into cancer diagnostics, cytology, infectious disease diagnostics, neuroscience, and immunology. The cancer diagnostics segment accounted for the largest share of the global market. This can be attributed to the high demand of FISH in the detection of cellular and genetic markers in cancers such as HER2, ALK, and ROS.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=212028829

Hospitals & diagnostic laboratories accounted for the fastest-growing end user segment of the ISH market

Based on the end user, the in situ hybridization market is segmented into hospital & diagnostic laboratories, academic & research institutes, CROs, and pharmaceutical & biotechnology companies. The hospital & diagnostic laboratories segment accounted for the largest share of the ISH market in 2019. This can be attributed to the increasing number of molecule-based screening, increasing number of specialty diagnostic tests performed in hospital laboratories, the rising number of in-house diagnostic procedures, and the rising trend of establishing in-house diagnostic capabilities in hospitals.

North America accounted for the largest share of the ISH market

North America accounted for the largest share of the global in situ hybridization market, followed by Europe. The large share of the North American region can be attributed to the presence of major players operating in the ISH market in the US, the rising incidence of cancer and infectious diseases, and the increasing adoption of CDx assay kits.

The prominent players operating in the in situ hybridization market are Abbott Laboratories (US), F. Hoffmann-La Roche Ltd (Switzerland), Agilent Technologies, Inc. (US), and Danaher Corporation (US).

Abbott Laboratories (US) has the largest market share in the in situ hybridization market. The company has gained its leadership through its VYSIS FISH platform and provides products and software for different types of cancer and prenatal and postnatal diagnosis. The company focuses on launching technologically advanced and innovative products in the market, such as kits, reagents, buffers, probes, and accessories. With its wide product portfolio, constant focus on R&D activities, and strategic collaborations, the company has created a strong foothold in the ISH market. The company has a strong presence in North America and the APAC and distribution networks and subsidiaries

Roche (Switzerland) is a world leader in IVD and tissue-based cancer diagnostics. The company has revolutionized cancer diagnostics across the globe through its cutting-edge testing automation. The company’s portfolio of more than 250 cancer tests and associated instruments makes it the leading global supplier of cancer diagnostic systems to the pathology market. The company’s new launches were focused mainly on cancer diagnostics. Its recent collaborations demonstrate a focus on expanding its diagnostic business and increasing accessibility for customers. Roche has shown a focus on differentiating its products in this market—as evident from the company’s emphasis on product innovation. It has launched innovative products over the last three years. For example, in 2019, the company introduced the VENTANA HER2 Dual ISH companion diagnostic test.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=212028829

Molecular Biology Enzymes Market - Technological Advancements in the Life Science Industry

Objectives of the Study:

# To define and measure the global molecular biology enzymes and kits & reagents market on the basis of product, application, end user, and region

# To identify key micromarkets and their drivers within the global molecular biology enzymes and kits & reagents market, which are expected to offer impressive growth opportunities in the coming years

# To identify trends and opportunities for stakeholders in the market and provide details of the competitive landscape for major market leaders

# To provide detailed information regarding the major factors influencing market growth (drivers, restraints, challenges, and opportunities)

# To forecast the size of the market segments with respect to four main regions, namely, North America (US and Canada), Europe (Germany, UK, France, and Rest of Europe), Asia Pacific (China, Japan, India, and Rest of APAC), and the Rest of the World (Latin America and Middle East & Africa)

# To analyze the market structure and profile key players in the global molecular biology enzymes and kits & reagents market and comprehensively evaluate their core competencies

# To track and analyze competitive landscape such as market share analysis and competitive leadership

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=164131709

Research Methodology:

Top-down and bottom-up approaches were used to validate the size of the global molecular biology enzymes industry and estimate the size of other dependent submarkets. Various secondary sources such as, Biotechnology and Biological Sciences Research Council, European Federation of Biotechnology, Genome Canada, National Human Genome Research Institute, World Health Organization, Federation of Asian and Oceanian Biochemists and Molecular Biologists, World Intellectual Property Organization, Press Releases, directories, industry journals, databases, and annual reports of the companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market.

Expected Revenue Growth:

The global molecular biology enzymes and kits & reagents market is projected to reach USD 13.60 Billion by 2022 from USD 6.52 Billion in 2017, at a CAGR of 15.8% during the forecast period.

Growth Influencing Factors:

The key factors driving the growth of this market include increased research activities and R&D investments in the life science industry, rising number of genome projects, technological advancements in the life science industry, and rising incidence of infectious diseases and genetic disorders. However, the privacy concerns related to genetic information and limited reimbursements for genetic testing may hinder the growth of this market to a certain extent.

By end user, academic & research institutes to hold the largest market share in 2017

Based on end user, the market is segmented into academic & research institutes, hospitals & diagnostic centers, pharmaceutical & biotechnology companies, and other end users (contract research organizations (CROs), food & beverage companies, and forensic agencies). The academic & research institutes segment is expected to command the largest share of the molecular biology enzymes and kits & reagents market in 2017. The large share of this segment can be attributed to the increasing research activities backed by funding from government and private organizations.

North America to dominate the market in 2017

In 2017, North America is expected to account for the largest share of the molecular biology enzymes and kits & reagents market, followed by Europe, Asia Pacific (APAC), and the Rest of the World (Latin America and the Middle East & Africa). Factors such as increasing research funding for genomics research, rising number of pharmaceutical and biotechnology companies, favorable reimbursement scenario for molecular diagnostics, and growing prevalence of target indications are contributing to the large share of North America.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=164131709

Global Key Players:

The molecular biology enzymes and kits & reagents market is well established owing to the dominance by prominent market players. In 2016, Thermo Fisher (US), Merck (Germany), and Illumina (US) held a share of 70% to 75% of the overall market.

Thermo Fisher Scientific dominated the molecular biology enzymes and kits & reagents market in 2016. The company provides a wide range of products in this market, including transfection reagents, cloning kits, cloning reagents, PCR enzymes & master mixes, PCR reagents, DNA extraction reagents & kits, and genome editing kits.

Merck designs and manufactures products for academic research markets, applied testing customers, the pharmaceutical & biotechnology industry, and molecular diagnostics laboratories. With the acquisition of Sigma-Aldrich Corporation (US), Merck secured the second-leading position in the global market (with a share of 23.1% in 2016). Sigma-Aldrich was one of the leading developers, manufacturers, and distributors of molecular biology enzymes and kits & reagents.

Some of the other players competing in this market are Illumina (US), QIAGEN (Netherlands), New England Biolabs (US), Promega (US), Agilent (US), Roche (Switzerland), Takara Bio (Japan), Bio Basic (Canada), Jena Bioscience (Germany), and Molecular Biology Resources (US).

Read Detailed Article@
https://www.marketsandmarkets.com/Market-Reports/molecular-biology-enzymes-kits-reagents-market-164131709.html

Environmental Testing Equipment Market - Get More Details About Global Leaders

Growth in the environmental testing devices market can be attributed to factors such as the rising levels of environmental pollution worldwide, increasing government regulations and initiatives for environmental protection, privatization of environmental testing services, and increasing focus on wastewater treatment. On the other hand, high capital investments for accurate and sensitive analytical testing and lack of supporting infrastructure and skilled professionals are expected to limit market growth to a certain extent during the forecast period.

The global environmental testing equipment market is expected to reach USD 2.9 billion by 2023 from USD 2.1 billion in 2018, at a CAGR of 7.1%.

The major players in the environmental testing equipment analysis market include Agilent Technologies (US), Thermo Fisher Scientific (US), Waters Corporation (US), Shimadzu Corporation (Japan), Bruker (US), PerkinElmer (US), SCIEX (a subsidiary of Danaher) (US), JEOL (Japan), Analytik Jena (Germany), and Merck KGaA (Germany). The analysis of market developments between 2016 and 2018 showed that market players adopted growth strategies such as product launches, strategic acquisitions, expansions, partnerships, agreements, and collaborations to strengthen their product portfolios and maintain a competitive position in the environmental testing equipment analysis market.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=149706080

In 2017, Agilent technologies held the dominant position in the environmental testing devices market. This can be attributed to the extensive product portfolio of analytical technologies, including chromatography, molecular spectroscopy, and mass spectrometry that the company offers. The firm strives to maintain its leading position by engaging in inorganic and organic growth strategies such as product launches, acquisitions, collaborations, and expansions.

The increase in the revenue of the Life Sciences and Applied Markets segment (offering chromatography and spectrometry instruments) was led by its growth in applied markets such as environmental, chemical and energy, and food. Agilent adopted the strategies of acquisitions, collaborations, and expansions to improve its market presence and maintain its leadership position in the market. For instance, in 2018, Agilent established a new logistics hub in Shanghai to enable the rapid delivery of the company’s instrument parts, supplies, and consumables to laboratories in China.

In 2017, Thermo Fisher Scientific was the second-largest player in the environmental testing equipment analysis market. The company’s leading position can be attributed to the growth in its sales, which was particularly strong in Asia. The sale towards each of the company's primary end-user markets also grew, including environmental industries. Thermo Fisher’s strong geographic presence is another asset for the company, with a presence in over 150 countries worldwide.

It sells its products and services through direct sales with the assistance of customer-service professionals, e-commerce, and third-party distributors. The company is equipped with a sales workforce of 12,000 highly trained personnel to meet the technical needs of end users. The firm strives to maintain its leading position by focusing on product launches and other developments. In 2018, Thermo launched the TSQ Fortis Triple Quadrupole Mass Spectrometer, Q Exactive UHMR Hybrid Quadrupole-Orbitrap Mass Spectrometer, and ISQ EM Single Quadrupole Mass Spectrometer to strengthen its LC-MS platform.

Shimadzu Corporation was the third largest player in the environmental testing device market in 2017. The strong foothold of the company in the market can also be attributed to its versatile portfolio of environmental testing products offered via its Analytical and Measuring Instruments segment. In June 2017, Shimadzu acquired the French reagents manufacturer, Alsachim SAS, which will serve as the base of Shimadzu’s reagents business in Europe.

In 2017, the sales of the company’s liquid chromatographs, mass spectrometers, gas chromatographs, and other environmental instruments was strong in North America and China owing to the government policies strengthening pollution control measures. Shimadzu has an established its marketing and production bases all around the world.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=149706080

North America is expected to dominate the environmental testing equipment market during the forecast period

Geographically, North America is expected to dominate the global environmental testing equipment market in 2018, while the Asia Pacific region is expected to register the highest CAGR during the forecast period. The high growth in this region can be attributed to the rising outdoor air pollution levels, the availability of government funding, and stringent environmental monitoring regulations.

Transdermal Drug Delivery System Market - Collaborations Between Pharmaceutical Companies and Drug Delivery Firms

Research Methodologies:

Primary Research:

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report.

The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the transdermal drug delivery solutions market. The primary sources from the demand side include personnel from research organizations, academic institutes, and purchase managers.

# A robust primary research methodology has been adopted to validate the contents of the report
# Both telephonic and e-mail interviews of primary participants were conducted through questionnaires

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203190114

Market Size Estimation:

Top-down and bottom-up approaches were used to validate the size of the transdermal drug delivery systems market and estimate the size of other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

# The key players in the industry and markets have been identified through extensive secondary research.
# The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Expected Revenue Growth:

The transdermal drug delivery solutions market is expected to reach USD 7.1 billion by 2023 from an estimated USD 5.7 billion in 2018, at a CAGR of 4.5% during the forecast period (2018-2023). Market growth is largely driven by the global increase in the prevalence of chronic diseases. In addition, technological advancements in transdermal drug delivery systems are also expected to support market growth in the coming years.

Hisamitsu Pharmaceutical (Japan), Mylan (US), UCB (Belgium), Novartis (Switzerland), GlaxoSmithKline (UK), Abbvie (US), Boehringer Ingelheim (Germany), Johnson & Johnson (US), Endo International (Ireland), and Purdue Pharma (US) are the major players operating in the global transdermal drug delivery systems market. These players have adopted various growth strategies, such as product launches and enhancements; agreements, partnerships, mergers, and collaborations; acquisitions; and expansions to strengthen their presence in the global market. Product launches and partnerships have been the most widely adopted strategies by major players from 2015 to 2018. These strategies helped market players to offer innovate products and broaden their customer base.

In 2017, Hisamitsu Pharmaceutical (Japan), Mylan (US), Novartis (Switzerland), and Abbvie (US) together accounted for a share of ~55.0% of the transdermal drug delivery systems market.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=203190114

North America to dominate the transdermal drug delivery systems market in 2018

North America is expected to dominate the transdermal drug delivery solutions market in 2018. The large share of the North American transdermal drug delivery systems market can primarily be attributed to the rising prevalence of targeted diseases (such as chronic pain, central nervous system disorders, and cardiovascular diseases) in the region, the increasing use of contraceptives, and the increasing number of research activities related to transdermal drug delivery systems.

Enterome Bioscience (France) and Seres Therapeutics (US) are the Key Players in the Human Microbiome Market

The human microbiome market is projected to reach USD 1,598 million by 2028 from USD 894 million in 2025, at a CAGR of 21.3% from 2025 to 2028. The major factor driving the growth of the human microbiome market is the increasing focus on human microbiome therapy development.

The human microbiome as a validated target for drug development & development of human microbiome-based tests for early disease detection and diagnosis are also factors expected to support market growth. Increasing collaborations between private-public organizations are expected to provide significant growth opportunities for players in the human microbiome market.

Global Leaders:

The major players in the human microbiome market include Enterome Bioscience (France), Seres Therapeutics (US), 4D Pharma (UK), and Ferring Pharmaceuticals (Switzerland). Various growth strategies have been adopted by these players, such as agreements, collaborations, partnerships, and acquisitions to increase their presence in the global human microbiome market.

Download PDF Brochure@ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=37621904

Enterome Bioscience (France) is a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat microbiome-associated diseases with a focus on IBDs, Crohn’s, and cancer (glioblastoma, colon, pancreatic, lung, and breast) indications. To sustain its position in the human microbiome market, ENTEROME adopts various organic and inorganic growth strategies. The company has been consistently entering into agreements and partnerships with strong biopharmaceutical players, which will help it to expedite drug development for cancer and GI disorders.

In 2020, the company received funds of USD 52.6 million from investors, including SymBiosis, LLC (US), a microbiome-focused investment vehicle, and Takeda Pharmaceutical Company Limited (Japan) for the progress of clinical development of its therapeutic pipeline. This pipeline includes the first clinical trials of EO2401, a novel OncoMimic cancer immunotherapy.

R&D Capabilities: The company conducts fundraising rounds to create funding for its various projects to expand its presence human microbiome market. Since its establishment in 2012, the company has raised close to USD 121 million (EUR 100 million) in financing rounds with private equity funds (and strategic investors) and in loans.

Seres Therapeutics (US) is one of the emerging players operating in this market. The company is engaged in developing a range of novel therapeutic products based on the human microbiome. To sustain its position in the human microbiome market, Seres Therapeutics focuses on its products offered for the market. The company’s microbiome therapeutics platform allows to significantly reduces the time typically required to advance therapeutics to the clinic, and ultimately, to the market. The company’s SER-109 program for the treatment of recurrent C difficile infection is anticipated to be the first-ever FDA-approved microbiome therapy. This has helped the company to strengthen its market position in high-growth niche opportunities.

R&D Capabilities: Seres Therapeutics focuses on collaborations to expand its market position in the human microbiome market. In March 2019, Seres collaborated with AstraZeneca to advance the mechanistic understanding of the microbiome in augmenting the efficacy of cancer immunotherapy. Under the agreement, AstraZeneca will pay the company a total of USD 20,000 in three equal instalments.

COVID-19 Impact: The company reported revenues of USD 6.05 billion in the second quarter of 2020, which was lower than its reported revenue in the second quarter of 2019. The COVID-19 pandemic adversely impacted the company’s business, including preclinical studies and clinical trials.

Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=37621904

The Asia Pacific region is the fastest growing region of human microbiome research spending market in 2019

On the basis of region, the global human microbiome research spending market is segmented into four major geographies— North America, Europe, the Asia Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the global human microbiome research spending market in 2019.

In 2019, the Asia Pacific region is estimated to grow at the highest CAGR in the human microbiome research spending from 2020-2025.  Factors such as increasing focus on microbiome research and initiatives taken by public and private organizations to increase awareness regarding microbiome therapeutics, are driving the growth of the human microbiome market in the Asia Pacific (APAC) region.